Given that chronic low-grade inflammation is a hallmark of metabolic diseases, IL-33 has the potential to be used as a biological agent due to its role as an immunoregulatory cytokine with the capacity to suppress inflammatory responses (6). The gene discussed is IL33; the disease is metabolic disease.